← FDA DRUG APPROVALS

FDA ANDA · ANDA074439

NICARDIPINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA074439
TYPE
ANDA
ORIGINAL APPROVAL
1996-12-10
LATEST ACTION
2007-04-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

NICARDIPINE HYDROCHLORIDEDiscontinued
NICARDIPINE HYDROCHLORIDE 30MG · CAPSULE · ORAL
NICARDIPINE HYDROCHLORIDEDiscontinued
NICARDIPINE HYDROCHLORIDE 20MG · CAPSULE · ORAL

Approval history

2007-04-12Manufacturing (CMC) · Supplement 14AP
2002-07-29Manufacturing (CMC) · Supplement 8AP
2002-03-12Manufacturing (CMC) · Supplement 7AP
2000-01-28Manufacturing (CMC) · Supplement 6AP
1999-11-29Manufacturing (CMC) · Supplement 5AP
1999-11-26Manufacturing (CMC) · Supplement 4AP
1998-12-09Manufacturing (CMC) · Supplement 2AP
1998-11-10Manufacturing (CMC) · Supplement 3AP
1998-02-25Manufacturing (CMC) · Supplement 1AP
1996-12-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →